Advisory Board

GLOBAL CREDIBILITY · OPINION LEADERSHIP · SCALABILITY

The Advisory Board

President (1999-2015) and Honorary Life President (2015-) of the International Tennis Federation (ITF);
Twice and current IOC member, Coordinator for the Olympic Games Rio 2016, Tokyo 2020, Paris 2024 and Los Angeles 2028 (2010-2025),
President (2013-2025) of the Association of Summer Olympic International Federations (ASOIF),
Executive Committee Member (2008-2020) and Finance and Administration Commission President (2014-2020) of the World Anti-Doping Agency (WADA);

Most ancient and stephanophorus kir Ljubodrag Ljubomira Grujić, the bearer of domologos, Head of the House of Grujić and all affiliated entities, the most ancient House in Serbdom, creator of all national symbols of Serbia. Our archentity’s main activity is scientific and practical exploration of sovereignty – be it personal sovereignty in the modern day and age, societal sovereignty, nobilistic sovereignty, etc. and the accompanying symbology.
Knowing it and living opens the doors to the most fruitful existence with one caveat: this requires enormous amounts of data collected and properly domologically processed. To be wise nowadays, as this is indeed a modern version of wisdom, one needs knowledge unheard of in ancient times. Due to the linear nature of our consciousness, we as a House require our House knowledge and expirence to be recorded so that we could daily study it and be reminded! ‘House wisdom is constant learning, forgetting and re-learning of the data the House collected’
The amount of data thus recorded far surpasses any imperial library of the ancient times! This data, this living flow of our mindful existence, in the hands of lesser entities represents liability. It is therefore of the utmost importance to us to endorse the idea and plans for ‘data sovereignty’. We are most commited to this noble idea.

President of the Alpha Omega US Dental Foundation USA
Oral & Maxillofacial surgeon in the greater Philadelphia area. He graduated from the University of Pennsylvania in Philadelphia, Pennsylvania with a degree in economics, and earned his dental degree from Temple University’s Maurice H. Kornberg School of Dentistry where he received the award for outstanding student in Oral Surgery. He completed his postgraduate training in oral and maxillofacial surgery at Howard University Hospital and the District of Columbia General Hospital, both in Washington, Dr. Rothman serves as the chief of oral and maxillofacial surgery and senior attending at the Einstein Medical Center Philadelphia and holds a faculty position at the Kornberg School of Dental medicine at Temple University.
Dr. Rothman serves on the advisory board of Tel Aviv University’s dental school. He is a Governor of Tel Aviv University and a member of the Executive Board of the American Friends of Tel Aviv University.
He is a member of the Alpha Omega Dental Society and a founder of its Global Oral Health Initiative. He also serves on the board of trustees of Congregation Beth Sholom in Elkins Park, PA.

Iain De Havilland is the Founder/CEO of NADclinic Group, a global pioneer in performance medicine, cellular health and advanced longevity therapeutics, including NAD+, peptides and precision health optimisation.
For over a decade, Iain has worked at the intersection of diagnostics, NAD+ science, peptide therapeutics and personalised medicine, with a clear mission, to move longevity beyond hype and into measurable, outcome-led biological performance.
Under his leadership, NADclinic is building a scalable longevity medicine platform that combines next-generation delivery systems, biomarker-led intelligence and pharmaceutical-grade therapeutics, helping make advanced cellular health more accessible to clinics, practitioners and individuals worldwide.
Known for his direct approach, Iain is focused on scaling precise, preventative and personalised longevity medicine responsibly, democratising access to the tools, therapeutics and intelligence needed to live with greater energy, resilience and purpose.

Physician-entrepreneur and researcher bridging clinical laboratory medicine, longevity science, and healthcare innovation. He is the founder and Director of inolab®️ Pforzheim, a specialist haemostasis laboratory with supraregional referral coverage that he has built and led since 2023.
Medical Faculty Mannheim, Heidelberg University, where he earned his medical degree and completed his doctoral thesis (summa cum laude) on metabolic profiling for rapid identification of multidrug-resistant pathogens—a methodology with direct relevance to precision diagnostics and personalized therapeutic monitoring. In 2026, he received his Habilitation and Venia Legendi in Laboratory Medicine, establishing his standing as an independent academic researcher.
During the COVID-19 pandemic, Dr. Kittel demonstrated scalable operational leadership as Coordinator of CoVLAB, a mobile testing initiative backed by €5.8 million in external funding from the Baden-Württemberg Foundation.
Dr. Kittel’s current work at inolab®️ integrates advanced haemostasis diagnostics with a forward-looking perspective on biomarker-driven health monitoring, positioning his practice at the intersection of clinical excellence, research innovation, and entrepreneurial healthcare delivery.

Distinguished academic and researcher serving as Senior Professor at Mannheim University of Applied Sciences, where he holds the distinction of being the institution’s first senior professor. He leads the CeMOS (Center for Mass Spectrometry and Optical Spectroscopy), a major research center comprising five research groups and approximately 70 engineers, and also heads the Institute for Process Measurement Technology & Innovative Energy Systems (PI).
Professor Rädle’s career began in industry, where he spent over a decade at BASF SE in Ludwigshafen (1988–2000). During his tenure at one of the world’s leading chemical companies, he led the Optical Process Sensor Development department and later headed Fertilizer Formulation. This extensive industrial experience provided him with deep expertise in process analytics and practical applications of spectroscopic technologies.
His research focus centers on the development of optical, spectroscopic, and image-analytical sensors, with primary applications in Process Analytical Technology (PAT) for industrial processes and medical technology. Additionally, he advances developments in renewable energy systems. His scientific contributions are substantial, with 39 publications and over 3,400 citations documented across academic platforms, reflecting significant impact in his field and making him a versatile and influential figure in applied sciences.